Skip to content
evidenceevidencedemonstrativeFederal Criminal TrialDefense Exhibit 10685Contains calculations from customer-receipt and option or stock-proceeds rows in Exhibit 5172. It was also described in closing argument as a Theranos record reflecting more than $200 million in deferred revenue.← All Evidence
Demonstratives

Defense Exhibit 10685

Contains calculations from customer-receipt and option or stock-proceeds rows in Exhibit 5172. It was also described in closing argument as a Theranos record reflecting more than $200 million in deferred revenue.

Exhibit 10685Option/stock proceeds summaryTheranos record reflecting more than $200 million in deferred revenue
3 mentions

Mentions (3)